Vestal Point Capital, LP Chimerix Inc Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Chimerix Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,400,000 shares of CMRX stock, worth $6.38 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,400,000
Previous 1,400,000
-0.0%
Holding current value
$6.38 Million
Previous $1.3 Billion
274.19%
% of portfolio
0.29%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
75Shares Held
36.7MCall Options Held
182KPut Options Held
108K-
Ra Capital Management, L.P. Boston, MA8.8MShares$40.1 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$18.4 Million0.0% of portfolio
-
Monaco Asset Management Sam2.82MShares$12.9 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$10.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$10.2 Million0.11% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $400M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...